The European Commission Friday announced plans to sign its first deal with a drugmaker for a potential coronavirus vaccine, an agreement that could secure 300 million doses on behalf of all EU members.
The deal with Frances Sanofi is not yet finalized and is being described as an “envisaged contract” that would “provide for an option for all EU member countries to purchase the vaccine.” The announcement comes following talks between the Commission and Sanofi, with Commission President Ursula von der Leyen promising that “more will follow soon.”
“We are in advanced discussions with several other companies. While we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies,” she said in a statement.
The Commission hopes to sign an advance purchase agreement with Sanofi for the 300 million doses using financing from its Emergency Support Instrument.
In the statement, the Commission also appeared to express support for the Gavi, the Vaccine Alliances COVAX scheme, designed to provide equal access to COVID-19 vaccines. While not mentioning the scheme by name, the Read More – Source
The European Commission Friday announced plans to sign its first deal with a drugmaker for a potential coronavirus vaccine, an agreement that could secure 300 million doses on behalf of all EU members.
The deal with Frances Sanofi is not yet finalized and is being described as an “envisaged contract” that would “provide for an option for all EU member countries to purchase the vaccine.” The announcement comes following talks between the Commission and Sanofi, with Commission President Ursula von der Leyen promising that “more will follow soon.”
“We are in advanced discussions with several other companies. While we do not know today which vaccine will work best in the end, Europe is investing in a diversified portfolio of promising vaccines, based on various types of technologies,” she said in a statement.
The Commission hopes to sign an advance purchase agreement with Sanofi for the 300 million doses using financing from its Emergency Support Instrument.
In the statement, the Commission also appeared to express support for the Gavi, the Vaccine Alliances COVAX scheme, designed to provide equal access to COVID-19 vaccines. While not mentioning the scheme by name, the Read More – Source
